BusinessActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 14, 2017, 12:03 PM UTC
BusinessActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 14, 2017, 12:03 PM UTC
BusinessActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 14, 2017, 12:03 PM UTC
BusinessActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 14, 2017, 12:03 PM UTC
BusinessActinium Pharmaceuticals to Present at Source Capital Group’s 2017 Disruptive Growth & Healthcare ConferenceBy Nasdaq OMXFeb 13, 2017, 9:15 PM UTC
BusinessActinium Pharmaceuticals’ Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple MyelomaBy Nasdaq OMXFeb 13, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals’ Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple MyelomaBy Nasdaq OMXFeb 13, 2017, 12:01 PM UTC
BusinessRecent Publication Highlights Proof-of-Concept Data Supporting the Diagnostic Potential of Phosphatidylserine-Positive Exosomes in Ovarian CancerBy Nasdaq OMXFeb 9, 2017, 1:05 PM UTC
